The intrathecal injection of a selective GPR109A agonist (MK1903) significantly attenuated thermal hyperalgesia in lupus mice, while this treatment did not alter the sensory perception in normal control mice. The gene discussed is HCAR2; the disease is systemic lupus erythematosus.